TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
1.341
+0.031 (2.38%)
Nov 5, 2024, 4:00 PM EST - Market closed
TNF Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 4.66 | 5.44 | 5.52 | 6.42 | 2.95 | 5.76 | |
Research & Development | 6.47 | 7.87 | 9.07 | 6.75 | 2.47 | 3.63 | |
Operating Expenses | 13.4 | 16.36 | 15.28 | 28.2 | 8.3 | 9.39 | |
Operating Income | -13.4 | -16.36 | -15.28 | -28.2 | -8.3 | -9.39 | |
Interest Expense | - | - | - | -0.61 | -1.19 | -0.25 | |
Interest & Investment Income | 0.29 | 0.46 | 0.08 | 0.01 | 0 | - | |
Other Non Operating Income (Expenses) | -4.41 | 12.08 | - | - | - | - | |
EBT Excluding Unusual Items | -17.51 | -3.82 | -15.2 | -28.8 | -9.49 | -9.64 | |
Gain (Loss) on Sale of Investments | 0 | 0 | -0 | -0 | - | - | |
Other Unusual Items | -0.18 | -0.18 | 0 | -1.09 | - | - | |
Pretax Income | -17.69 | -4 | -15.2 | -29.89 | -9.49 | -9.64 | |
Net Income | -17.69 | -4 | -15.2 | -29.89 | -9.49 | -9.64 | |
Preferred Dividends & Other Adjustments | 5.67 | 4.22 | - | - | - | - | |
Net Income to Common | -23.35 | -8.22 | -15.2 | -29.89 | -9.49 | -9.64 | |
Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 1 | 1 | |
Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 1 | 1 | |
Shares Change (YoY) | 44.02% | 19.18% | 10.88% | 24.23% | -25.94% | - | |
EPS (Basic) | -11.94 | -5.33 | -11.74 | -25.61 | -10.10 | -7.60 | |
EPS (Diluted) | -11.94 | -5.33 | -11.74 | -25.61 | -10.10 | -7.60 | |
Free Cash Flow | -9.67 | -12.98 | -12.27 | -19.52 | -4.66 | -5.32 | |
Free Cash Flow Per Share | -4.94 | -8.42 | -9.48 | -16.72 | -4.96 | -4.19 | |
EBITDA | - | - | - | -28.18 | -8.28 | -9.37 | |
D&A For EBITDA | - | - | - | 0.02 | 0.02 | 0.02 | |
EBIT | -13.4 | -16.36 | -15.28 | -28.2 | -8.3 | -9.39 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.